17133-Urothelial Cancer-NA-129

Urothelial Cancer

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Address

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.